A Stanford specialist clarifies misconceptions about acute flaccid myelitis, a rare complication of certain viral infections in children.
Dorothy Tovar, a graduate student and Boston native, explains her research and her career goals in this In the Spotlight feature.
One hundred years after the 1928 influenza epidemic, flu remains a threat to society today, several Stanford emergency medicine clinicians explain.
A team of Stanford Biodesign innovators has developed a video to increase awareness in India of a serious heart condition, RHD.
Decision scientist Mehlika Toy is working with the WHO to help eliminate the public health burden of hepatitis B by the year 2030.
The ratio between a certain types of immune cells is able to predict whether latent TB will shift into an active infection, new research has found.
A system that circulates cold water may be the key to improving protective suits for infectious disease responses, firefighting and more.
Scientists at Stanford find a biomarker for flu susceptibility, enabling predictions of if someone is going to fall ill to the virus after being exposed.
Antiretroviral therapy, a breakthrough treatment for HIV infection, suppresses the levels of circulating HIV viral particles in the blood. When it works, cancer rates drop, according to a new study. Still, even when the therapy is successful, HIV-positive individuals retain elevated rates of cancer.
A hitherto unheralded set of telltale enzymes may prove to be perfect targets for shooting down a gang of nasty bacterial pathogens collectively called S. aureus.
Stanford's Stephen Luby discusses how the little-known but deadly Nipah virus is transmitted, in light of news of an outbreak in southern India.
The sex ratio of a social group can influence the risk of getting an infectious disease as much as, and sometimes more, than an individual's traits, a Rice University study finds.
A Stanford study explores the factors that are important to help a community recover from a disaster such as an epidemic.
Many healthy newborns are getting antibiotics they don’t need, potentially causing harmful changes in their gut bacteria, but new Stanford research suggests a solution.
A technique for growing sticky films of bacteria into elaborate microscopic images could reveal how potentially dangerous biofilms grow and transmit antibiotic resistance, and could lead to novel biomaterials or synthetic microbial communities.
Many infectious diseases are marked by cyclical ups and downs. Stanford's David Schneider takes a creative approach to making sense of them.